Thursday, October 16, 2025
HomeIndustriesBiotechnology

Biotechnology

AbbVie Announces European Commission Approval of SKYRIZI for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who...

Brooks PathFinder System selected by Lifeblood for Sample Management

Brooks Automation, a global leader in innovative design, manufacture and commercialization of robotic automation for laboratories, is proud to announce its successful appointment as...

Read Magazine’s Weekly News Roundup With HawkEye 360, RealTruck, SEI , Analog Devices, Cemvita, Teledyne And More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL...

Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World

Analog Devices, Inc., a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, announced a strategic alliance to accelerate the development of a...
0FansLike
0FollowersFollow
spot_img

Hot Topics